Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 15, 2021

SELL
$242.95 - $284.63 $279,392 - $327,324
-1,150 Closed
0 $0
Q2 2020

Jul 23, 2020

BUY
$258.66 - $342.55 $297,459 - $393,932
1,150 New
1,150 $308,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Pioneer Trust Bank N A Portfolio

Follow Pioneer Trust Bank N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pioneer Trust Bank N A, based on Form 13F filings with the SEC.

News

Stay updated on Pioneer Trust Bank N A with notifications on news.